107 related articles for article (PubMed ID: 28923653)
1. Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
Frey A; Ecker EM; Piras-Straub K; Walker A; Hofmann TG; Timm J; Singer BB; Gerken G; Herzer K
Transplant Proc; 2017 Oct; 49(8):1947-1955. PubMed ID: 28923653
[TBL] [Abstract][Full Text] [Related]
2. The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype.
Frey A; Piras-Straub K; Walker A; Timm J; Gerken G; Herzer K
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29111569
[TBL] [Abstract][Full Text] [Related]
3. The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis.
Basso G; Felipe CR; Cristelli MP; Mansur Siliano J; Viana L; Ferreira Brigido AN; Stopa Martins SB; de Castro Lima Santos DW; Aguiar WF; Tedesco-Silva Junior H; Medina-Pestana JO
Transpl Infect Dis; 2018 Aug; 20(4):e12919. PubMed ID: 29797676
[TBL] [Abstract][Full Text] [Related]
4. Bile acids specifically increase hepatitis C virus RNA-replication.
Chhatwal P; Bankwitz D; Gentzsch J; Frentzen A; Schult P; Lohmann V; Pietschmann T
PLoS One; 2012; 7(4):e36029. PubMed ID: 22558311
[TBL] [Abstract][Full Text] [Related]
5. Host cell mTORC1 is required for HCV RNA replication.
Stöhr S; Costa R; Sandmann L; Westhaus S; Pfaender S; Anggakusuma ; Dazert E; Meuleman P; Vondran FW; Manns MP; Steinmann E; von Hahn T; Ciesek S
Gut; 2016 Dec; 65(12):2017-2028. PubMed ID: 26276683
[TBL] [Abstract][Full Text] [Related]
6. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticosteroids increase cell entry by hepatitis C virus.
Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
[TBL] [Abstract][Full Text] [Related]
8. mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation.
Gedaly R; De Stefano F; Turcios L; Hill M; Hidalgo G; Mitov MI; Alstott MC; Butterfield DA; Mitchell HC; Hart J; Al-Attar A; Jennings CD; Marti F
Transplantation; 2019 Apr; 103(4):705-715. PubMed ID: 30451741
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
Esmat GE; Al Akel W; Abdel Aziz RA; Al Sayed Taha A; Sabry D; Rashed LA; Mostafa A; El Kazaz AY; Ahmed SH
J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.
Shao RX; Zhang L; Peng LF; Sun E; Chung WJ; Jang JY; Tsai WL; Hyppolite G; Chung RT
J Virol; 2010 Jun; 84(12):6060-9. PubMed ID: 20375166
[TBL] [Abstract][Full Text] [Related]
11. Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.
Kowala-Piaskowska A; Słuzewski W; Figlerowicz M; Mozer-Lisewska I
Infection; 2007 Jun; 35(3):175-9. PubMed ID: 17565459
[TBL] [Abstract][Full Text] [Related]
12. Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4.
Lee SS; Ferenci P
Antivir Ther; 2008; 13 Suppl 1():9-16. PubMed ID: 18432158
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection.
Feliu A; Carrión JA; Massaguer A; Martínez-Bauer E; García-Retortillo M; González P; Costa J; Sánchez-Tapias JM; Forns X
J Viral Hepat; 2006 Aug; 13(8):544-51. PubMed ID: 16901285
[TBL] [Abstract][Full Text] [Related]
14. SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations.
Costa R; Todt D; Zapatero-Belinchón F; Schenk C; Anastasiou OE; Walker A; Hertel B; Timmer L; Bojkova D; Ruckert M; Sarrazin C; Timm J; Lohmann V; Manns MP; Steinmann E; von Hahn T; Ciesek S
J Hepatol; 2019 Apr; 70(4):603-614. PubMed ID: 30472319
[TBL] [Abstract][Full Text] [Related]
15. Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation.
Ishida H; Kato T; Takehana K; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(1):127-33. PubMed ID: 23806690
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
Soliman A; Fathy A; Khashab S; Shaheen N; Soliman M
Exp Clin Transplant; 2013 Oct; 11(5):408-11. PubMed ID: 24128134
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates.
Wagner D; Kniepeiss D; Schaffellner S; Jakoby E; Mueller H; Fahrleitner-Pammer A; Stiegler P; Tscheliessnigg KH; Iberer F
Int Immunopharmacol; 2010 Aug; 10(8):990-3. PubMed ID: 20483386
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
Weng L; Tian X; Gao Y; Watashi K; Shimotohno K; Wakita T; Kohara M; Toyoda T
Biochim Biophys Acta; 2012 Dec; 1820(12):1886-92. PubMed ID: 22954804
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.
Smolic R; Smolic M; Andorfer JH; Wu CH; Smith RM; Wu GY
World J Gastroenterol; 2010 May; 16(17):2100-8. PubMed ID: 20440850
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
